YZILabs Accuses 10X Capital of Violating Securities Act
YZILabs Management delivered a letter to 10X Capital Asset Management, its affiliated entities, and certain related individuals regarding its significant concerns that 10X Capital appears to have breached Sections 13(d) and 16(a) of the Securities Exchange Act of 1934 in connection with 10X Capital's ownership of shares of common stock of CEA Industries. YZi said, "Section 13(d)(1) of the Exchange Act requires a person to file a Schedule 13D within five business days of such person's ownership exceeding 5% of a public issuer's outstanding stock. Section 13(d)(3) of the Exchange Act requires that when two or more persons or entities act together with respect to the acquisition, holding, or voting of a public company's securities, their beneficial ownership is aggregated for purposes of determining their disclosure obligations. Based on publicly available information, YZi Labs believes that 10X Capital has beneficially owned in excess of 5% of BNC's outstanding common stock since at least late 2025 and has failed to file a Schedule 13D disclosing the formation of such group. In addition, it is unclear whether Hans Thomas, a Founding Partner of 10X Capital and a director of BNC, beneficially owns any BNC securities. Despite currently serving as a director of the Company, Mr. Thomas has not filed a Form 3 with the Securities and Exchange Commission and therefore has not complied with his initial ownership reporting obligations under Section 16(a) of the Exchange Act. In contrast, YZi Labs promptly filed its initial Schedule 13D with the SEC on November 26, 2025, within the required timeframe, based upon the Company's share repurchases pushing YZi Labs over the 5% reporting obligation threshold. Subsequently and in response to the Company's FY Q2 2026 Form 10-Q, which disclosed the issuance of approximately 1,300,000 outstanding shares, YZi Labs' direct ownership fell below the 5% threshold. YZi Labs decided to form a group with certain other shareholders for purposes of Section 13(d)(3), in order to maintain the consent solicitation process and the ability to exercise certain rights under Nevada law. To be clear, YZi Labs has at all times filed its initial Schedule 13D and amendments thereto within the timeframes required under Section 13(d) of the Exchange Act."